Victory sveikatingumo studija, MB - financials and debts

Company age: 3 y. 5 mo.

Update

Victory sveikatingumo studija - Company finances

EUR
2023
From: 2023-04-19
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 325 3,951 4,325
Profit before tax -1,154 -3,198 -2,688
Net profit -1,154 -3,198 -2,688
Equity -1,153 -4,351 -4,522
Liabilities 1,317 5,934 5,696
Non-current assets 0 847 457
Current assets 164 641 717
Total assets 164 1,488 1,174
Taxes paid
STI taxes 349 465 16
Financial indicators
Revenue change y/y - +1115.7% +9.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. -703.7% -214.9% -229.0%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - - -
Profit margin Net profit margin. Shows the overall profitability of the company. -355.1% -80.9% -62.2%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. -355.1% -80.9% -62.2%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 2,963 -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Victory sveikatingumo studija - Social security debts

The company had no debts to Sodra

Victory sveikatingumo studija - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Victory sveikatingumo studija, MB (company code 306302706) is a small partnership operating in other human health activities n.e.c. In 2025, its revenue increased to €4.3K, up 9.5% year on year, following €4.0K in 2024 and €325 in the shortened 2023 period. Over the two-year span, revenue rose strongly, but the business remained loss-making throughout. Net profit was -€1.2K in 2023, -€3.2K in 2024 and -€2.7K in 2025, with the latest profit margin at -62.2%. The 2025 result therefore shows some improvement versus 2024, although profitability stayed negative. The balance sheet remained small: total assets were €1.2K in 2025, compared with €1.5K in 2024 and €164 in 2023. Equity stayed negative at -€4.5K, while liabilities were €5.7K. Long-term assets were €457 and short-term assets €717 in 2025. Return ratios and leverage indicators are heavily affected by the negative equity base, so they should be read with caution. Asset turnover stood at 3.68x in 2025, indicating that the small asset base generated relatively high revenue.